Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02844504 · ClinicalTrials.gov registry record · NA
Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02844504: Completed NA study, sponsored by Kessler Foundation.
NCT02844504 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02844504, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Breast cancer patients often suffer from long-term physical symptoms of weakness. In this study, investigators propose to compare how two different low intensity physical exercise training programs can improve handgrip strength for breast cancer patients with symptoms of weakness. Using brain imaging, the study will also investigate changes in brain structure, and muscle activity associated with handgrip.
Primary Outcome
Primary outcome will be used to compare pre to post change in maximum force contraction at the end of the 6-week intervention between groups.Similar comparison will be done between retention test (4 weeks after training) and posttest (immediately after training).
Interventions
- BEHAVIORAL Low Intensity Exercise Training 1
- BEHAVIORAL Low Intensity Exercise Training 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-09 |
| Phase | NA |
What the finished NCT02844504 record still lists
NCT02844504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Intensity Exercise Training 1 is the first listed.
NCT02844504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02844504 about?
NCT02844504 is a clinical study titled "Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness". Breast cancer patients often suffer from long-term physical symptoms of weakness. In this study, investigators propose to compare how two different low intensity physical exercise training programs can improve handgrip strength for breast cancer patients with symptoms of weakness. Using brain imagin...
What is the current status of trial NCT02844504?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-05. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02844504?
The interventions under investigation include: Low Intensity Exercise Training 1 (BEHAVIORAL), Low Intensity Exercise Training 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02844504?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02844504's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia